老年患者因二级预防植入植入式心律转复除颤器的结局:来自NCDR ICD登记研究
该研究基于美国国家心血管数据登记ICD登记中2006至2009年间956家医院首次因二级预防植入ICD的12,420例Medicare受益人,评估2年内死亡、住院和入住专业护理机构的风险。结果显示2年死亡风险21.8%,随年龄增长而升高(≥80岁较<70岁调整风险比2.01),住院和入住专业护理机构风险同样随年龄升高。
要点
- 2年死亡风险总体21.8%,<70岁为14.7%,≥80岁为28.9%(调整风险比2.01)。
- 2年累积住院率65.4%,<70岁为60.5%,≥80岁为71.5%(调整风险比1.27)。
- 入住专业护理机构累积发生率<70岁为13.1%,≥80岁为31.9%(调整风险比2.67),风险在最初30天最高。
核心结论
- 近五分之四接受二级预防ICD的老年患者至少生存2年,但住院和入住专业护理机构率较高,尤其在最年长患者中,提示设备植入后存在大量照护需求。
研究设计与样本
- 回顾性队列研究,纳入美国国家心血管数据登记ICD登记中2006至2009年间956家美国医院首次因二级预防植入ICD的12,420例Medicare受益人。
- 按年龄分层(65至69岁、70至74岁、75至79岁、≥80岁),使用Medicare索赔数据评估2年内死亡、住院和入住专业护理机构的风险,并用多变量模型评估年龄与结局的调整关联。
主要发现
- 植入时平均年龄75岁,25.3%的患者<70岁,25.7%的患者≥80岁。
- 2年死亡风险总体为21.8%,<70岁为14.7%,≥80岁为28.9%(调整风险比2.01;95%置信区间1.85至2.33;趋势P值<0.001)。
- 2年累积住院率为65.4%,<70岁为60.5%,≥80岁为71.5%(调整风险比1.27;95%置信区间1.19至1.36;趋势P值<0.001)。
- 入住专业护理机构的累积发生率<70岁为13.1%,≥80岁为31.9%(调整风险比2.67;95%置信区间2.37至3.01;趋势P值<0.001);入住专业护理机构风险在最初30天最高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical trials of implantable cardioverter-defibrillators (ICDs) for secondary prevention of sudden cardiac death were conducted nearly 2 decades ago and enrolled few older patients. OBJECTIVES: This study assessed morbidity and mortality of older patients receiving ICDs for secondary prevention in contemporary clinical practice. METHODS: We identified 12,420 Medicare beneficiaries from the National Cardiovascular Data Registry ICD Registry undergoing first-time secondary prevention ICD implantation between 2006 and 2009 in 956 U.S. hospitals. Risks of death, hospitalization, and admission to a skilled nursing facility (SNF) were assessed over 2 years in age strata (65 to 69, 70 to 74, 75 to 79, and ≥80 years of age) using Medicare claims. The adjusted association between age and outcomes was evaluated using multivariable models. RESULTS: The mean age was 75 years at the time of implantation; 25.3% were <70 years of age and 25.7% were ≥80 years of age. Overall, the risk of death at 2 years was 21.8%, ranging from 14.7% among those <70 years of age to 28.9% among those ≥80 years of age (adjusted risk ratio [aRR]: 2.01; 95% confidence interval [CI]: 1.85 to 2.33; p for trend <0.001). The cumulative incidence of hospitalizations was 65.4%, ranging from 60.5% in those <70 years of age to 71.5% in those ≥80 years of age (aRR: 1.27; 95% CI: 1.19 to 1.36; p for trend <0.001). The cumulative incidence of admission to a SNF ranged from 13.1% among those <70 years of age to 31.9% among those ≥80 years of age (aRR: 2.67; 95% CI: 2.37 to 3.01; p for trend <0.001); SNF admission risk was highest in the first 30 days. CONCLUSIONS: Almost 4 in 5 older patients receiving a secondary prevention ICD survives at least 2 years. High hospitalization and SNF admission rates, particularly among the oldest patients, identify substantial care needs after device implantation.
引用
- Betz JK, Katz DF, Peterson PN, et al. Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry. J Am Coll Cardiol. 2017. PMID: 28104069. doi:10.1016/j.jacc.2016.10.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。